gualoupi injection

Gualoupi injection is a Traditional Chinese Medicine (TCM) pharmaceutical product derived from the peel of *Trichosanthes kirilowii* Maxim. It is widely utilized in China for the treatment of cardiovascular conditions, specifically coronary heart disease and stable angina pectoris. The pharmacological profile of Gualoupi injection includes the dilation of coronary arteries, improvement of myocardial microcirculation, and inhibition of platelet aggregation, which collectively help to alleviate myocardial ischemia. It is typically administered intravenously as an adjunct to standard cardiovascular therapies. The product is manufactured by Shandong Buchang Pharmaceuticals and has been the subject of post-marketing Phase 4 clinical evaluations to further establish its efficacy and safety in broader patient populations.

Brand names

Xintong

Other names

Gualoupi ZhusheyeTrichosanthes kirilowii peel injection